Doğum Tarihi: 11 Şubat 1966 Doğum Yeri : Ankara Medeni Hali
A50. Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldı N, Guner R
Yüklə 225,77 Kb.
|
A50. Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldı N, Guner R, Koksal I, Kurt H, Cicek Senturk G. Supportive treatment in Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Diseases 2012;12(9):805-11. doi: 10.1089/vbz.2011.0896. Epub 2012 May 18. A51. Koruk ST, Erdem H, Koruk I, Erbay A, Tekce YT, Erbay AR, Dayan S, Deveci O, Inan A, Engin DO, Guner R, Dikici N, Kartal E, Kurtaran B et al. Management of Brucella Endocarditis: The results of Gulhane Study. Int J Antimicrob Agents 2012 Aug;40(2):145-50. doi: 10.1016/j.ijantimicag.2012.04.009. Epub 2012 Jun 21. A52. T Güven, A Kaya Kalem, R Guner, GR Yılmaz, F Civelek, MA Taşyaran. Ateş ve Lenfadenopati Etyolojisinde Kikuchi Hastalığı: Bir Olgu Sunumu. J Infect Microb Antimicrob 2012:1(1);1-3. A53. Kaklikkaya N, Sancaktar M, Guner R, Buruk CK, Koksal I, Tosun I, Aydin F. Hepatitis B virus genotypes and subgenotypes in the Eastern Black Sea region of Turkey. Saudi Med J. 2012 ;33(6):622-6. A54. Guner R, Tasyaran MA, Keske S, Hasanoglu I, Kalem AK, Yapar D, Gulen TA, Neselioglu S, Isikoglu S, Erel O. Relationship between total thiol status and thrombocytopenia in patients with Crimean-Congo hemorrhagic fever. Southeast Asian J Trop Med Public Health 2012;43(6):1411-8. A55. Güven T, Eser FC, Yılmaz GR, Guner R, Taşyaran MA. P. falciparum malaria related with travel: four cases. Turkiye Parazitol Derg. 2013;37(3):225-8. A56. Koklu S, Gulsen MT, Tuna Y, Koklu H, Yuksel O, Yilmaz B, Karaca C, Ataseven H, Guner R, Kucukazman M, Kockar C, Demir M, Poyrazoglu OK, Ibis M, Purnak T, Etgul S, Alkan E, Coban S, Gokturk S, Biyik M, Baykal O, Basar O, Koklu N, Tatar G, Simsek H. Lamivudine treatment failure risks in chronic hepatitis B patients with low viral load. Digestion. 2013;88(4):266-71.
G, Guner R, Duygu F, Beeching NJ. Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey. J Infect. 2015 Jul 18. pii: S0163-4453(15)00226-1. doi: 10.1016/j.jinf.2015.07.003. [Epub ahead of print] PubMed PMID: 26196597. A66. Gulen TA, Guner R, Celikbilek N, Keske S, Tasyaran M. Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant acinetobacter baumannii. Int J Infect Dis. 2015 Sep;38:32-5. doi: 10.1016/j.ijid.2015.06.014. Epub 2015 Jun 28. PubMed PMID: 26129972. A67. Örmeci N, Özbaş B, Güner R, Özkan H, Yalçı A, Çoban Ş, Dökmeci A, Kalkan Ç, Akıncı H, Yüksel O, Başar Ö, Yüksel İ, Balık İ. Tenofovir-best hope for treatment of chronic hepatitis B infection? Turk J Gastroenterol. 2015 Jul;26(4):322-7. A66. Kocak Tufan Z, Hasanoglu I, Kolgelier S, Alisik M, Ergin M, Yilmaz GR, Tasyaran MA, Erel O & Guner R. A retrospective controlled study of thiol disulfide homeostasis as a novel marker in Crimean Congo hemorrhagic fever. Redox Report 2016. A67. Leblebicioglu H, Sunbul M, Guner R, Bodur H, Bulut C, Duygu F, Elaldi N, Cicek Senturk G, Ozturk Z, Yilmaz G, Fletcher TE, Beeching NJ. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002–2014: a multicentre retrospective cross-sectional study.Clin Microbiol Infect 2016;22(4):387e. http://dx.doi.org/10.1016/j.cmi.2015.11.024 3.B. ULUSLARARASI BİLİMSEL TOPLANTILARDA SUNULAN VE BİLDİRİ KİTABINDA BASILAN BİLDİRİLER : B1.Aydın K, Köksal İ, Aydın S, Kadimoğlu V, Kaklıkkaya N, Tekelioğlu Y, Yenilmez E, Caylan R, Örem A, Aydın F, Kalyoncu N, Köksal H. Therapeutic efficacy of granulocyte colony-stimulating factor and imipenem in rats with intra-abdominal sepsis. 10th Mediterranean Congress of Chemotherapy, Abstract Book, 219, Antalya, Türkiye, 20-25 October 1996. B2. Aydın K, Köksal İ, Çaylan R, Volkan S, Turgut H, Usta T. Etiologic distribution of acute viral hepatitis the south eastern Anatolian region of Turkey and the role of hepatitis E, The 4th Congress of the Mediterranean Society of Infectious and Parasitic Diseases and the Arab Society of Chemotherapy, Microbiology & Infectious Diseases. Cairo, Egypt, 18-21 October 1997. B3. Aydın K, Köksal İ, Çaylan R, Ayaz C, Usta T, Günel A. Hepatitis E comparison of seropositivity in two different geographic regions. The 4th Congress of the Mediterranean Society of Infectious and Parasitic Diseases and the Arab Society of Chemotherapy, Microbiology & Infectious Diseases, Cairo, Egypt, 18-21 October 1997. B4. Volkan S, Köksal I, Aydın K, Çaylan R, Öksüz R. Infectious causes in febrile neutropenia episodes of hematological cancer patients. 3rd International Symposium on Febrile Neutropenia. Abstract book 62, Belgium1997. B5. Aydın K, Köksal İ, Çaylan R, Volkan S, Öksüz R. Prospective responses to recombinant hepatitis B vaccination applied by two different immunization schedules in Turkish population. 8th International Congress on Infectious Diseases, P.54.015, Boston, Massachusetts, USA, May 15 to 18, 1998. B6. Çaylan, R. Aydın, K. Köksal, İ. Öksüz, R. Kostakoğlu, U. Efficacy of interferon alfa therapy in chronic hepatitis B in Turkish population: A long-term follow-up trial. 8th International Congress on Infectious Diseases, P.92.030, Boston, Massachusetts, USA, May 15 to 18, 1998. B7. Köksal İ, Aydın K, Volkan S, Çaylan R, Öksüz R, Ovalı E, Aydın F. Comparison of imipenem-cilastatin/amikacin versus ceftazidime/amikasin in the empiric treatment of febrile episodes in neutropenic patients. 8th International Congress on Infectious Diseases, p:59.024, Boston, Massachusetts, USA, May 15 to 18, 1998. B8. Aydın K, Çaylan R, Köksal I. Evaluation of prognosis, immunization and management of tetanus cases. Clinical Microbiology and Infection, 5(supp 3),182, March 1999. B9. Köksal İ, Aydın K, Çaylan R, Kostakoğlu U. Interferon-alpha plus famciclovir therapy in patients with chronic hepatitis B: preliminary report. J Antimicrobial Chemotherapy, 44(supp A), 45-46, 1999. B10. Köksal İ, Aydın K, Çaylan R. Adjunctive dexamethasone therapy for pneumococcal meningitis in adults: preliminary report. 9th International Congress on Infectious Diseases, 55, Buenos Aires, Argentina, April 10-13, 2000. B11. Leblebicioglu H, Eroglu C and members of the Hepatitis Study Group. Acute hepatitis B virus infection in Turkey: epidemiology and genotype distribution. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, California, September 27-30, 2002. B12. Çaylan R, Kaklıkkaya N, Aydın K, Aydın F, Yılmaz G, Çubukcu K, Özgümüş B, Köksal I. An epidemiological analysis of Stenotrophomonas maltophilia strains. Clinical Microbiology and Infection, 8(supp 1), P1436, 2002. B13. Çaylan R, Aydın K, Bayraktar Ö, Aktoz G, Köksal İ, Sarı A. Listeria monocytogenes meningitis complicated by granuloma formation in cerebellar pedincule. Clinical Microbiology and Infection, 8(supp 1),P1555, 2002. B14. Koksal I, Caylan R, Sırmatel F, Ersoy Y, Aygen B, Sunbul M. Daily interferon in chronic hepatitis B patients: a multicenter study from Turkey. Clinical Microbiology and Infection, 8(supp 1), P1289, 2002. B15. Caylan R, Kaklıkkaya N, Yılmaz G, Aydın K, Aydın F, Koksal I. Nosocomial bacteremia due to Stenotrophomonas maltophilia: an analysis of 41 episodes. Clinical Microbiology and Infection, 9(supp 1), P572, 2003. B16. Koksal I, Caylan R, Kaklıkkaya N, Aktoz Boz G, Aydın K, Aydın F. YMDD mutations during lamivudine therapy in patients with chronic hepatitis B. Clinical Microbiology and Infection, 9(supp 1), P1673, 2003. B17. Gundes S, Kolayli F, Demirdağ K, Gunaydin M, Altindis M, Caylan R, Hosoglu S, Vahaboglu H. Ceftazidim-resistant Escherichia coli and Klebsiella pneumoniae isolates from four Turkish hospitals: identification of TEM-, SHV- and GES-type b-lactamases. Clinical Microbiology and Infection, 10 (suppl 3), P1718, 2004. B18. Tosun I, Udo E, Noronha B, Caylan R, Aydin F, Yetiskul S. Characterisation of rifampicin resistant Staphylococcus aureus from a Turkish hospital. 5th Annual Scientific Meeting, Antimicrobials, Australian Society for Antimicrobials, P5, 2004. B19. Rosenthal VD, Leblebicioglu H, Ozgultekin A, Arıkan AÖ, Sardan YC, Koksal I, Yalcın N, Usluer G, Ulusoy S, Tulunay M, Yıldırım G, Aydın K, Esen S, Turhan O, Ozgunes I, Arda B, Oral M, Yıldırım A, Caylan R, Ulger F, Unal S, Keskin S, Erben N, Bacakoglu F, Unal N. Extra lenght of stay and device-associated nosocomial infection rates in intensive care units in nine hospitals of Turkey. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy 2005;K-1916. B20. Yılmaz G, Caylan R, Topbaş M, Aydın K, Koksal I. Evaluation of the contributary effect of education on the determination and prevention of risk factors associated with intravascular catheter-related infections. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, USA; 2005, K-2225. B21. Koksal I, Aydın K, Caylan R, Leblebicioglu H, Rosenthal VD. Effect of education and performance feedback on handwashing in hospital of Trabzon, Turkey. The Society for Healthcare Epidemiology of America's 15th Annual Scientific Meeting, P114, 2005. B22. Leblebicioglu H, Yilmaz H, Tasova Y, Alp E, Saba R, Caylan R, Bakir M, Akbulut A, Arda B. Epidemiologic and clinical aspects of infective endocarditis in Turkey. 15th European Congress of Clinical Microbiology and Infection, Copenhagen, Denmark 2-5 April 2005, P1288. B23.Rosenthal VD, Venkatachalam N, Vilins M, Pawar M, Ruiz J, Linares C, Oral M, Bravo L, Akgun N, Moreno A, Lezma M, Topeli A, Sussmann O, Oropeza M, Kardenas Y, Barba EJ, Zeggwagh A, Bernate P, Sztokhamer D,Keskin S, Çaylan R et al. Mortality risk factor analysis at hospitals members of the International Nosocomial Infection Control Consortium in Argentina, Brazil, Colombia, India, Mexico, Morocco, Peru and Turkey. Sixth Congress of the International Federation of Infection Control, İstanbul, Turkey; 13-16 Oct 2005, PP55. B24. Sucu N, Aydın K, Koksal I, Caylan R, Yılmaz G. Crimean-Congo haemorrhagic fever in the East Black Sea region of Turkey: a report of 78 cases. 16th European Congress of Clinical Microbiology and Infectious Diseases, 1-4 Apr 2006; Nice, France; 2006;12(4):O102. B25. Aydın K, Yılmaz G, Aksoy F, Koksal I, Caylan R. An analysis of the factors effecting the prognose of tetanus in a university hospital between 1991 and 2005. 16th European Congress of Clinical Microbiology and Infectious Diseases, 1-4 Apr 2006; Nice, France; 2006;12 (4): P1094. B26.Koksal I, Yilmaz G, Aydin K, Sucu N, Caylan R. Determine variation of antimicrobial susceptibility patterns according to five years in intensive care unit of university hospital. 16th European Congress of Clinical Microbiology and Infectious Diseases, 1-4 Apr 2006; Nice, France; 2006;12(4):R1944. B27. Yılmaz G, Koksal I, Aydın K, Caylan R, Sucu N, Aksoy F. Risk factors of catheter-related infections in total parenteral nutrition catheterization. 12th International Congress of Infectious Diseases, 15-18 June 2006; Lisbon, Portugal, 2006;63.011. B28. Aydın K, Yılmaz M, Sonmez M, Aksoy F, Yılmaz G, Caylan R, Akdogan E, Sozen E, Durmus A, Sucu N, Koksal I, Omay SB, Ovali E. The role of antifungal treatment in the control of febrile neutropenia episodes. 12th International Congress of Infectious Diseases, 15-18 June 2006; Lisbon, Portugal; 2006;14.045. B29. Koksal I, Aydın K, Rosenthal VD, Caylan R, Senel AC. Effectiveness of outcome and process surveillance for reducing ventilator-associated pneumonia in a hospital of Turkey. Findings of the INCC. Am J Infect Control 2007;35(5):71. B30. Koksal I, Ozlu T, Bayraktar Saral O, Aydin K, Caylan R, Oztuna F, Bulbul Y, Yılmaz G, Sucu N and the Pneumonia Study Group. The aetiological agents in adult patients with acquired lower respiratory tract infections in Turkey. 17th European Congress of Clinical Microbiology and Infectious Diseases, 31 Mar-04 Apr 2007; Munich, Germany, 2007; P1198. B31. Ozgumus OB, Sandalli C, Caylan R, Tosun I, Aydin K, Koksal I, Sevim A, Sevim-Celik E, Alpay-Karaoglu S, Colakoglu F, Sivri N, Kolayli F, Yesilgil-Atasoy P. A molecular perspective on integron-associated and transferable antibiotic resistance in clinical and aquatic isolates of Gram-negative bacteria in northern region of Turkey. EHRLICH-II-2nd World Conference on Magic Bullets, pA244, October 3-5, Nürnberg, Germany, 2008 (oral presentation). B32.Caylan R, Keske S, Durmaz T, Keles T, Tasyaran MA. A case of brucella endocarditis in association with superficial artery thrombosis. 13th International Congress on Infectious Diseases Kuala Lumpur, Malaysia, June 19-22, 2008. B33. Keske S, Caylan R, Hasanoglu I, Kaya A, Altinkaya S, Tasyaran MA. The efficacy of entecavir treatment in chronic hepatitis B patients. 5th APASL Single Topic Conference, 17-20 May 2009, Istanbul-Turkey. 2009. p 145. B34. Caylan R, Keske S, Arslan T, Akman S, Tasyaran MA. Liver histologic findings of the patients whose ALT is persistantly normal and HBV DNA is higher than 104 copy/mL. 5th APASL Single Topic Conference, 17-20 May 2009, Istanbul-Turkey. 2009. p 145. B35. Caylan R, Yapar D, Taser B, Tasyaran MA. A clinical study of the efficacy in the treatment of hepatitis B with pegile interferon. 5th APASL Single Topic Conference, 17-20 May 2009, Istanbul-Turkey. 2009. p 148. B36. Arslan T, Yapar D, Bilir H, Caylan R, Tasyaran MA. A peg-interferon and ribavirin combination treatment for chronic hepatitis C patients. 5th APASL Single Topic Conference, 17-20 May 2009, Istanbul-Turkey. 2009. p 172. B37. Caylan R, Yapar D, Sarıcı M, Tasyaran MA. Cutaneus necrosis after pegilated interferon B injection in a patient with chronic hepatitis B. 5th APASL Single Topic Conference, 17-20 May 2009, Istanbul-Turkey. 2009. p 148. B38. Caylan R, Yapar D, Keske S, Hasanoglu I, Tasyaran MA. Nosocomial transmission of Crimean-Congo haemorrhagic fever. 20th European Congress of Clinical Microbiology and Infectious Diseases, 10-13 April 2010, Vienna, Austria; 2010, R2339. B39. Caylan R, Keske S, Yapar D, Arslan T, Tasyaran MA. Evaluation of Crimean-Congo haemorrhagic fever patients: Epidemiological, clinical and laboratory features. 20th European Congress of Clinical Microbiology and Infectious Diseases 10-13 April 2010, Vienna, Austria; 2010, R2340. B40. Caylan R, Hasanoglu I, Yapar D, Tasyaran MA. A case of Crimean-Congo haemorhagic fever with acalculous cholecyctitis and intraabdominal abscess. 20th European Congress of Clinical Microbiology and Infectious Diseases, 10-13 April 2010, Vienna, Austria; 2010, P1405. B41. Guner R, Karahocagil M, Buyukberber M, Kandemir O, Ural O, Usluer G, Inan D, Koksal I, Baykam N, Hizel K, Yamazhan T, Esen S, Tasyaran M. Correlation Between Intrahepatic Hepatitis B Virus cccDNA Levels and Other Activity Markers in Patients with HBeAg-Negative Chronic Hepatitis B Infection. Hepatol Int. 21st Conference of the Asian Pacific Association for the Study of the Liver APASL 2011. 17-20 Feb 2011; Springer; 2011. p 155. B42. Guner R, Tasyaran M, Keske S, Hasanoglu I, Yapar D, Kaya Kalem A, Arslan Gulen T, Isikoglu S, Neselioglu S, Erel O. Strong relationship between total thiol status and thrombocytopenia in patients with Crimean-Congo haemorrhagic fever. 21st European Congress of Clinical Microbiology and Infectious Diseases; 7-10 May 2011; Milan, Italy. 2011; P1025. B43. Guner R, Hasanoglu I, Ascioglu S, Kaya Kalem A, Keske S, Tasyaran MA. Procedure specific surgical site infection rates in a tertiary care hospital in Turkey. 21st European Congress of Clinical Microbiology and Infectious Diseases; 7-10 May 2011; Milan, Italy. 2011; P1643. B44. Guner R, Hasanoglu I, Keske S, Tasyaran MA. Educational approach to reduce catheter related bloodstream infections and catheter related urinary tract infection rates in intensive care unit. 21st European Congress of Clinical Microbiology and Infectious Diseases; 7-10 May 2011; Milan, Italy. 2011; P2587. B45. Yılmaz GR, Arslan Gulen T, Guven T, Guner R, Babacan T, Tasyaran MA. Colistin usage in infections due to multidrug resistant microorganisms: Clinical and microbiological response, toxicity. 4th Eurasia Congress of Infectious Diseases, Bosna&Herzegovina, June 1-5, 2011; P021. B46. Guven T, Arslan Gulen T, Yılmaz GR, Civelek Eser F, Guner R, Tasyaran MA. A case report: Neurobrucellosis mimicking demyelinating disease. 4th Eurasia Congress of Infectious Diseases, Bosna&Herzegovina, June 1-5, 2011; P083. B47. Yılmaz GR, Guven T, Guner R, Kekse S, Tasyaran MA. A health care associated pneumonia case due to colistin resistant Acinetobacter baumannii. 4th Eurasia Congress of Infectious Diseases, Bosna&Herzegovina, June 1-5, 2011; P067. B48. Guven T, Yılmaz GR, Guner R, Tasyaran MA. THe increasing resistance in nosocomial Acinetobacter isolates in Turkey:1993-2009. 4th Eurasia Congress of Infectious Diseases, Bosna&Herzegovina, June 1-5, 2011; P008. B49. Kandemir O, Guner R, Yamazhan T, Alakuş İ. The effecting risk factors on the results of peg-interferon alpha and ribavirin therapy in HCV genotype 1 patients. Hepatol Int. 22nd Conference of the Asian Pacific Association for the Study of the Liver APASL 2012. 16-19 Feb 2012; Taipei, Taiwan. Springer; 2012. p 178. B50. Tutuncu E, Guner R, Gurbuz Y, Kaya Kalem A, Ozturk B, Hasanoglu I, Sencan I, Tasyaran M. Adherence of nucleoside/nucleotide analogue treatment in patients with chronic hepatitis B. Hepatol Int. 22nd Conference of the Asian Pacific Association for the Study of the Liver APASL 2012. 16-19 Feb 2012; Taipei, Taiwan. Springer; 2012. p 114. B51. Guner R, Hızel K, Tutuncu E, Kandemir O, Inan D, Baykam N, Yamazhan T. Effectiveness and safety of long term entecavir treatment in anti HBV drug experienced and naïve patients: a multicenter study from Turkey. Hepatol Int. 22nd Conference of the Asian Pacific Association for the Study of the Liver APASL 2012. 16-19 Feb 2012; Taipei, Taiwan. Springer; 2012. p 110. B52. Yılmaz GR, Guner R, Guven T, Arslan Gulen T, Kaya Kalem A, Tasyaran MA. Clinical and microbiological efficacy and toxicity of different dosages of colistin in critically patients. 22 nd European Congress of Clinical Microbiology 2012. 31 March-3 April 2012; London, United Kingdom. 22nd c/o Congrex Switzerland; (Oral presentation) p 67. B53. Koksal I, Yılmaz G, Parlak M, Demirdal T, Kınıklı S, Candan M, Kaya A, Akhan S, Aydogdu O, Turgut H, Gurguz Y, Daglı O, Gokal A, Guner R, Kuruuzum Z, Tarakcı H, Beslen N on behalf of the Chronic Hepatitis C Study Group. Relationship between liver biopsy and noninvasive biochemical methods in determination of liver fibrosis in treatment naïve chronic hepatitis C patients : a multicenter study. 22 nd European Congress of Clinical Microbiology 2012. 31 March-3 April 2012; London, United Kingdom. 22nd c/o Congrex Switzerland; (Oral presentation) p 81. B54. Aslan Gulen T, Guner R, Yilmaz GR, Keske S, Tasyaran MA. Clinical impact and cost analysis of multidrug-resistant nosocomial Acinetobacter baumannii bacteraemia: a case control study. 22nd European Congress of Clinical Microbiology 2012. 31 March-3 April 2012; London, United Kingdom, R2555. B55. Yilmaz GR, Guven T, Guner R, Aslan Gulen T, Civelek F, Tasyaran MA. Two oropharyngeal tularaemia cases with pregnancy. 22nd European Congress of Clinical Microbiology 2012. 31 March-3 April 2012; London, United Kingdom, R2686 B57. Yilmaz GR, Guven T, Guner R, Kaya-Kalem A, Keske S, Tasyaran MA. Efficacy and toxicity of colistin usage in bloodstream infections due to multi-drug resistant Gram-negative microorganisms. First International Conference on Polymyxins. 26 pp., Prato, Italy, 2-4 May 2013. B58. Yilmaz GR, Guven T, Guner R, Izdes S, Eser F, Tasyaran MA. Evaluation of inhaled colistin treatment for ventilatory-associated pneumonia due to multi-drug resistant Acinetobacter baumannii: Preliminary report”, First International Conference on Polymyxins. 42 pp., Prato, Italy, 2-4 May 2013. B59. Civelek-Eser F, Yilmaz GR, Guven T, Guner R, Kocak Tufan Z, Tasyaran MA. A probable pulmoner candidiasis case after candidemia in an immuncompromized patient. The 5th EURASIA Congress of Infectious Diseases, Abstract Book. 256 pp., Tirana, Albania, May 2013. Yüklə 225,77 Kb. Dostları ilə paylaş:
|